advertisement
BMJ open 44
Showing records 1 to 25 | Display all abstracts in BMJ open98939 Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Garrison SR
BMJ open 2022; 12: e059711
99077 Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)
Forgetta V
BMJ open 2022; 12: e059021
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Sun Y
BMJ open 2022; 12: e053805
98890 Anxiety and depression in Chinese patients with glaucoma and its correlations with vision-related quality of life and visual function indices: a cross-sectional study
Wu N
BMJ open 2022; 12: e046194
99336 Prevalence of blindness and its determinants in Bangladeshi adult population: results from a national cross-sectional survey
Shakoor SA; Rahman M
BMJ open 2022; 12: e052247
98890 Anxiety and depression in Chinese patients with glaucoma and its correlations with vision-related quality of life and visual function indices: a cross-sectional study
Kong X
BMJ open 2022; 12: e046194
99077 Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)
Li R
BMJ open 2022; 12: e059021
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Chen A
BMJ open 2022; 12: e053805
98939 Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Kolber MR; Allan GM
BMJ open 2022; 12: e059711
98890 Anxiety and depression in Chinese patients with glaucoma and its correlations with vision-related quality of life and visual function indices: a cross-sectional study
Sun X
BMJ open 2022; 12: e046194
99077 Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)
Darmond-Zwaig C
BMJ open 2022; 12: e059021
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Zou M
BMJ open 2022; 12: e053805
99336 Prevalence of blindness and its determinants in Bangladeshi adult population: results from a national cross-sectional survey
Hossain AHME; Moniruzzaman M
BMJ open 2022; 12: e052247
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Zhang Y
BMJ open 2022; 12: e053805
98939 Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Bakal J
BMJ open 2022; 12: e059711
99077 Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)
Belisle A; Balion C
BMJ open 2022; 12: e059021
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Jin L
BMJ open 2022; 12: e053805
99336 Prevalence of blindness and its determinants in Bangladeshi adult population: results from a national cross-sectional survey
Bhuiyan MR
BMJ open 2022; 12: e052247
98939 Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Green L
BMJ open 2022; 12: e059711
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Li Y
BMJ open 2022; 12: e053805
99077 Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)
Roshandel D
BMJ open 2022; 12: e059021
98939 Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Singer A
BMJ open 2022; 12: e059711
99336 Prevalence of blindness and its determinants in Bangladeshi adult population: results from a national cross-sectional survey
Hakim F
BMJ open 2022; 12: e052247
98939 Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Trueman DR
BMJ open 2022; 12: e059711
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Zheng D
BMJ open 2022; 12: e053805
